Biochemical relapse in prostate cancer: is PSA promoting stress and anxiety?
Slovin, S.
Medgenmed Medscape General Medicine 4(3): 11
2002
ISSN/ISBN: 1531-0132 PMID: 12466754 Document Number: 540673
Document emailed within 1 workday
Related Documents
Murray, N.P.; Aedo, S.óc.; Fuentealba, C.; Reyes, E.; Minzer, S.; Salazar, A.íb. 2019: Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer Archivos Espanoles de Urologia 72(5): 471-482Hallstrom, C. 1984: Practical aspects of the use of beta-blockers in anxiety stress: morbid anxiety Postgraduate Medical Journal 60(Suppl 2): 26-28
Zouhair, A.; Jichlinski, P.; Mirimanoff, R.é-O. 2005: Biochemical failure after curative treatment for localized prostate cancer Revue Medicale Suisse 1(44): 2844-2846; 2848
Shain, S.A.; Huot, R.I.; Gorelic, L.S.; Smith, G.C. 1984: Biochemical and morphological characterization of clonal AXC rat prostate cancer cells Cancer Research 44(5): 2033-2042
Romas, N.A.; Veenema, R.J.; Hsu, K.C.; Tomashefsky, P.; Lattimer, J.K.; Tannenbaum, M. 1979: Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods Transactions of the American Association of Genito-Urinary Surgeons 71: 26-30
Shiota, M.; Yokomizo, A.; Naito, S. 2014: The development of therapeutics targeting oxidative stress in prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2131-2135
Uzawa, E. 2002: Influence of degree of stress and anxiety and stress cognition on nicotine dependence Nihon Shinkei Seishin Yakurigaku Zasshi 22(5): 212
Rosser, C.J.; Kuban, D.A.; Lee, S-Joon.; Levy, L.B.; Pettaway, C.; Kamat, A.M.; Chichakli, R.; Lee, A.; Cheung, R.M.; Sanchez-Ortiz, R.; Pisters, L.L. 2004: Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer Journal of the National Medical Association 96(7): 939-944
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Salmon, P. 1992: Anxiety and stress in surgical patients British Journal of Hospital Medicine 48(9): 531-533
Zhu, X-Dong.; Zheng, A.; Wang, Z-Qian.; Shao, Q. 2018: Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population Zhonghua Nan Ke Xue 24(2): 142-146